N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production

Platon Peristeris, Burton D. Clark, Silvia Gatti, Raffaella Faggioni, Alberto Mantovani, Manuela Mengozzi, Scott F. Orencole, Marina Sironi, Pietro Ghezzi

Research output: Contribution to journalArticle

207 Citations (Scopus)

Abstract

TNF is a major mediator in the pathogenesis of endotoxic shock, and its inhibition has a protective effect in various animal models of sepsis or endotoxin (lipopolysaccharide, LPS) toxicity. LPS treatment also induces an oxidative damage mediated by increased production of reactive oxygen intermediates. N-Acetylcysteine (NAC) is an antioxidant and a precursor of the synthesis of glutathione (GSH) and was reported to protect against LPS toxicity and LPS-induced pulmonary edema. In this study we investigated the effect of NAC on TNF production and LPS lethality in mice. The results indicated that oral administration of NAC protects against LPS toxicity and inhibits the increase in serum TNF levels in LPS-treated mice. The inhibition was not confined to the released form of TNF, since NAC also inhibited LPS-induced spleen-associated TNF. On the other hand, the inhibitor of GSH synthesis, dl-buthionine-(SR)-sulfoximine (BSO), had the opposite effect of potentiating LPS-induced TNF production, and this was associated with a decrease in liver GSH levels. Repletion of liver GSH with NAC reversed this effect. NAC was also active in inhibiting TNF production and hepatotoxicity in mice treated with LPS in association with a sensitizing dose of Actinomycin D. These data indicate that GSH can be an endogenous modulator of TNF production in vivo. On the other hand, NAC pretreatment did not inhibit other effects of LPS, particularly induction of serum IL-6, spleen IL-1α, and corticosterone, in the same experimental model, suggesting that the observed effect could be specific for TNF.

Original languageEnglish
Pages (from-to)390-399
Number of pages10
JournalCellular Immunology
Volume140
Issue number2
DOIs
Publication statusPublished - Apr 1 1992

Fingerprint

Acetylcysteine
Glutathione
Lipopolysaccharides
Tumor Necrosis Factor-alpha
Spleen
Buthionine Sulfoximine
Liver
Dactinomycin
Pulmonary Edema
Septic Shock
Corticosterone
Serum
Interleukin-1
Endotoxins
Oral Administration
Interleukin-6
Sepsis
Theoretical Models
Animal Models
Antioxidants

ASJC Scopus subject areas

  • Cell Biology
  • Immunology

Cite this

Peristeris, P., Clark, B. D., Gatti, S., Faggioni, R., Mantovani, A., Mengozzi, M., ... Ghezzi, P. (1992). N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cellular Immunology, 140(2), 390-399. https://doi.org/10.1016/0008-8749(92)90205-4

N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. / Peristeris, Platon; Clark, Burton D.; Gatti, Silvia; Faggioni, Raffaella; Mantovani, Alberto; Mengozzi, Manuela; Orencole, Scott F.; Sironi, Marina; Ghezzi, Pietro.

In: Cellular Immunology, Vol. 140, No. 2, 01.04.1992, p. 390-399.

Research output: Contribution to journalArticle

Peristeris, P, Clark, BD, Gatti, S, Faggioni, R, Mantovani, A, Mengozzi, M, Orencole, SF, Sironi, M & Ghezzi, P 1992, 'N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production', Cellular Immunology, vol. 140, no. 2, pp. 390-399. https://doi.org/10.1016/0008-8749(92)90205-4
Peristeris, Platon ; Clark, Burton D. ; Gatti, Silvia ; Faggioni, Raffaella ; Mantovani, Alberto ; Mengozzi, Manuela ; Orencole, Scott F. ; Sironi, Marina ; Ghezzi, Pietro. / N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. In: Cellular Immunology. 1992 ; Vol. 140, No. 2. pp. 390-399.
@article{b85b4b2e985149f881bb7717c0b62971,
title = "N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production",
abstract = "TNF is a major mediator in the pathogenesis of endotoxic shock, and its inhibition has a protective effect in various animal models of sepsis or endotoxin (lipopolysaccharide, LPS) toxicity. LPS treatment also induces an oxidative damage mediated by increased production of reactive oxygen intermediates. N-Acetylcysteine (NAC) is an antioxidant and a precursor of the synthesis of glutathione (GSH) and was reported to protect against LPS toxicity and LPS-induced pulmonary edema. In this study we investigated the effect of NAC on TNF production and LPS lethality in mice. The results indicated that oral administration of NAC protects against LPS toxicity and inhibits the increase in serum TNF levels in LPS-treated mice. The inhibition was not confined to the released form of TNF, since NAC also inhibited LPS-induced spleen-associated TNF. On the other hand, the inhibitor of GSH synthesis, dl-buthionine-(SR)-sulfoximine (BSO), had the opposite effect of potentiating LPS-induced TNF production, and this was associated with a decrease in liver GSH levels. Repletion of liver GSH with NAC reversed this effect. NAC was also active in inhibiting TNF production and hepatotoxicity in mice treated with LPS in association with a sensitizing dose of Actinomycin D. These data indicate that GSH can be an endogenous modulator of TNF production in vivo. On the other hand, NAC pretreatment did not inhibit other effects of LPS, particularly induction of serum IL-6, spleen IL-1α, and corticosterone, in the same experimental model, suggesting that the observed effect could be specific for TNF.",
author = "Platon Peristeris and Clark, {Burton D.} and Silvia Gatti and Raffaella Faggioni and Alberto Mantovani and Manuela Mengozzi and Orencole, {Scott F.} and Marina Sironi and Pietro Ghezzi",
year = "1992",
month = "4",
day = "1",
doi = "10.1016/0008-8749(92)90205-4",
language = "English",
volume = "140",
pages = "390--399",
journal = "Cellular Immunology",
issn = "0008-8749",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production

AU - Peristeris, Platon

AU - Clark, Burton D.

AU - Gatti, Silvia

AU - Faggioni, Raffaella

AU - Mantovani, Alberto

AU - Mengozzi, Manuela

AU - Orencole, Scott F.

AU - Sironi, Marina

AU - Ghezzi, Pietro

PY - 1992/4/1

Y1 - 1992/4/1

N2 - TNF is a major mediator in the pathogenesis of endotoxic shock, and its inhibition has a protective effect in various animal models of sepsis or endotoxin (lipopolysaccharide, LPS) toxicity. LPS treatment also induces an oxidative damage mediated by increased production of reactive oxygen intermediates. N-Acetylcysteine (NAC) is an antioxidant and a precursor of the synthesis of glutathione (GSH) and was reported to protect against LPS toxicity and LPS-induced pulmonary edema. In this study we investigated the effect of NAC on TNF production and LPS lethality in mice. The results indicated that oral administration of NAC protects against LPS toxicity and inhibits the increase in serum TNF levels in LPS-treated mice. The inhibition was not confined to the released form of TNF, since NAC also inhibited LPS-induced spleen-associated TNF. On the other hand, the inhibitor of GSH synthesis, dl-buthionine-(SR)-sulfoximine (BSO), had the opposite effect of potentiating LPS-induced TNF production, and this was associated with a decrease in liver GSH levels. Repletion of liver GSH with NAC reversed this effect. NAC was also active in inhibiting TNF production and hepatotoxicity in mice treated with LPS in association with a sensitizing dose of Actinomycin D. These data indicate that GSH can be an endogenous modulator of TNF production in vivo. On the other hand, NAC pretreatment did not inhibit other effects of LPS, particularly induction of serum IL-6, spleen IL-1α, and corticosterone, in the same experimental model, suggesting that the observed effect could be specific for TNF.

AB - TNF is a major mediator in the pathogenesis of endotoxic shock, and its inhibition has a protective effect in various animal models of sepsis or endotoxin (lipopolysaccharide, LPS) toxicity. LPS treatment also induces an oxidative damage mediated by increased production of reactive oxygen intermediates. N-Acetylcysteine (NAC) is an antioxidant and a precursor of the synthesis of glutathione (GSH) and was reported to protect against LPS toxicity and LPS-induced pulmonary edema. In this study we investigated the effect of NAC on TNF production and LPS lethality in mice. The results indicated that oral administration of NAC protects against LPS toxicity and inhibits the increase in serum TNF levels in LPS-treated mice. The inhibition was not confined to the released form of TNF, since NAC also inhibited LPS-induced spleen-associated TNF. On the other hand, the inhibitor of GSH synthesis, dl-buthionine-(SR)-sulfoximine (BSO), had the opposite effect of potentiating LPS-induced TNF production, and this was associated with a decrease in liver GSH levels. Repletion of liver GSH with NAC reversed this effect. NAC was also active in inhibiting TNF production and hepatotoxicity in mice treated with LPS in association with a sensitizing dose of Actinomycin D. These data indicate that GSH can be an endogenous modulator of TNF production in vivo. On the other hand, NAC pretreatment did not inhibit other effects of LPS, particularly induction of serum IL-6, spleen IL-1α, and corticosterone, in the same experimental model, suggesting that the observed effect could be specific for TNF.

UR - http://www.scopus.com/inward/record.url?scp=0026603481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026603481&partnerID=8YFLogxK

U2 - 10.1016/0008-8749(92)90205-4

DO - 10.1016/0008-8749(92)90205-4

M3 - Article

C2 - 1544168

AN - SCOPUS:0026603481

VL - 140

SP - 390

EP - 399

JO - Cellular Immunology

JF - Cellular Immunology

SN - 0008-8749

IS - 2

ER -